– UK, Cambridge – ieso Digital Health, the innovative healthcare company developing AI-driven evidence-based mental health solutions, today announced the appointment of Dave Icke to its Board of Directors as Executive Chair., leading the day-to-day management and chairing the Board of Directors.
About David Icke
As a results-driven strategic business leader driving product innovation, commercialization, and market growth, Dave has extensive international experience in leadership roles at large payer/provider organizations, and medical device and digital health companies. He is an advisor to Takeda Digital Ventures, which invests in companies that improve patient outcomes and the delivery of care, and several other entrepreneurial digital health startups in the US. Before ieso, Dave was VP of Digital Health Products at Humana, where he led a team that built end-to-end connected digital health solutions focused on telehealth and remote monitoring.
He previously launched the Digital Health business at Becton Dickinson for chronic disease self-management and served as founding CEO at wearable biosensor company mc10 (acquired by Medidata). Earlier in his career,r Dave held several general management roles at Teradyne, with P&L responsibility for annual sales of up to $500M, and helped scale KLA’s microchip inspection business from $50M to $700M in sales. He earned his bachelor’s degree in Chemical Engineering from Stanford University and his M.B.A. from Harvard Business School.
“It is both an honor and an exciting opportunity to join the ieso team. I admire ieso for its commitment to making evidence-based mental healthcare more effective and accessible,” said Dave Icke. “I am inspired by ieso’s mission, impressed by its deep science and clinical expertise, and am determined to expand its reach – first in the US – to ensure more individuals have access to the level of outcomes-driven, value-based, quality mental healthcare ieso is known for.”
About ieso Digital health
ieso is turning real-world clinical data into products that make mental healthcare more effective and accessible than ever before. The company is developing AI-driven evidence-based mental health solutions to democratize access to mental health therapy at scale. The company currently provides type therapy to more than 20 million adults through the UK National Health Service. ieso’s research has been published in several peer-reviewed journals including the Lancet and JAMA, shaping our understanding of scalable digital mental healthcare solutions.
For more information: https://www.iesogroup.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.